Visits: 2392, Avg visit time (secs): 226,13 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1255 | 52,47% | |
| /pfizer/efsd-pfizer-rfa09.html | 249 | 10,41% |
| /programmes.html | 170 | 7,11% |
| /amylin/efsd-amylin-rfa09.html | 141 | 5,89% |
| /lilly/fellowships/efsd-lilly-fship09.html | 76 | 3,18% |
| /msd/albert-renold/efsd-msd-arenold.html | 43 | 1,80% |
| /lifescan/efsd-lifescan-rfa09.html | 40 | 1,67% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 40 | 1,67% |
| /regulations.html | 29 | 1,21% |
| /msd/clinical/efsd-msd-clinical-rfa10.html | 21 | 0,88% |
| /novartis/efsd-novartis-rfa09.html | 20 | 0,84% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1171 | 48,95% |
| /pfizer/efsd-pfizer-rfa09.html | 225 | 9,41% |
| /sanofi-aventis/micro_macro/s-a 10 rfa.html | 189 | 7,90% |
| /recipients.html | 113 | 4,72% |
| /msd/albert-renold/efsd-msd-arenold.html | 74 | 3,09% |
| /amylin/efsd-amylin-rfa09.html | 54 | 2,26% |
| /lilly/fellowships/efsd-lilly-fship09.html | 50 | 2,09% |
| /lifescan/efsd-lifescan-rfa09.html | 44 | 1,84% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 40 | 1,67% |
| /programmes.html | 38 | 1,59% |
| /home.html | 37 | 1,55% |